Most Opdivo (nivolumab) side effects resolve within about four to five weeks, but the timeline varies dramatically depending on which organ system is affected. Some side effects clear in days, while others, particularly those involving hormone-producing glands, can last months or become permanent. Understanding what to expect for your specific side effect can help you navigate treatment and recovery with less uncertainty.
General Timeline for Onset and Resolution
Opdivo works by releasing the brakes on your immune system so it can attack cancer cells, but that same unleashed immune response can sometimes target healthy tissue. These immune-related side effects follow a roughly predictable pattern. A pooled analysis of over 8,400 patients across 23 clinical trials found that most immune-related side effects resolve within a median of 4.5 weeks from the time they first appear.
The order in which side effects tend to show up is also consistent. Infusion reactions appear earliest, at around 3 weeks into treatment. Neurological symptoms follow at about 4 weeks, skin reactions at roughly 4 weeks, and gastrointestinal problems at around 6 weeks. Endocrine side effects, those involving hormone-producing glands like the thyroid or pituitary, tend to develop later and take far longer to resolve.
Skin Reactions
Rashes, itching, and other skin changes are among the most common Opdivo side effects. They typically appear within the first month of treatment and are usually among the faster side effects to clear up. Most skin reactions fall within the general 4- to 5-week resolution window, especially when managed with topical treatments or short courses of oral medication. Severe skin reactions are rare but take longer to resolve and may require treatment to be paused.
Gastrointestinal Side Effects
Diarrhea and colitis (inflammation of the colon) typically develop around six weeks into treatment. For mild cases, symptoms often improve within a few weeks once treatment is adjusted. More severe colitis usually requires steroid treatment, with a taper lasting 4 to 6 weeks after symptoms improve. In cases that don’t respond to steroids, additional immunosuppressive treatment can bring resolution in a median of about 2.7 weeks, though individual cases range widely from under a week to over four months.
Lung Inflammation
Pneumonitis, or inflammation of the lungs, occurs in roughly 3.5% to 19% of patients depending on the type of cancer being treated and whether Opdivo is combined with other therapies. The onset is unpredictable, ranging from days to years after the first infusion. Recovery typically involves a steroid taper lasting 4 to 6 weeks, though some patients need tapers extending to 6 months. Symptoms like shortness of breath and cough generally improve within the first few weeks of steroid treatment, but full lung recovery can trail behind.
Endocrine Side Effects Can Be Permanent
This is where the timeline differs most from other side effects. Endocrine problems, those affecting glands that produce hormones, have the longest median resolution time at nearly 29 weeks (about 7 months). And “resolution” in this context is somewhat misleading, because many endocrine side effects never fully reverse.
Hypothyroidism (underactive thyroid) is the most common endocrine side effect. In most cases, it remains permanent and requires lifelong thyroid hormone replacement. The good news is that thyroid replacement is straightforward, inexpensive, and well-tolerated. Your thyroid levels are simply monitored with periodic blood tests, and you take a daily pill to replace what your thyroid no longer makes.
Less commonly, Opdivo can cause inflammation of the pituitary gland (hypophysitis), leading to deficiencies in multiple hormones. Recovery depends on which hormonal pathways are damaged. The body’s ability to produce the stress hormone cortisol rarely recovers, meaning lifelong replacement is usually necessary. Thyroid function controlled by the pituitary may recover over time, but this isn’t guaranteed.
In rare cases, Opdivo triggers a form of diabetes that requires permanent insulin therapy. Unlike type 2 diabetes, this immune-mediated form doesn’t respond to immunosuppressive treatment and won’t go away after stopping Opdivo.
Why Side Effects Can Appear After Treatment Ends
One of the more unsettling aspects of Opdivo is that new side effects can emerge months after your last infusion. The drug has a blood half-life of about one week, meaning it’s largely cleared from your bloodstream within a month or two. But that doesn’t mean its effects are gone. Opdivo binds to a receptor on immune cells called PD-1, and that binding persists much longer than the drug itself circulates. After just a single dose, roughly 80% of targeted receptors remain occupied for up to 90 days. After three doses, about 40% of receptors stay occupied for more than 8 months.
This lingering immune activation explains why delayed side effects happen. Researchers have documented new immune-related side effects appearing a median of 6 months after the last dose, with the longest reported case occurring 28 months later. One reported case involved colitis developing 23 months after the final infusion of a similar checkpoint inhibitor. These delayed events are uncommon, with only a few dozen cases documented in the medical literature, but they’re worth being aware of. Any new symptoms in the months following treatment should be evaluated with your oncology team, even if your last infusion was many months ago.
What Recovery Looks Like in Practice
For most non-endocrine side effects, the recovery process follows a similar pattern. If symptoms are mild, Opdivo may be continued while the side effect is managed. For moderate to severe reactions, treatment is paused and steroids are started. Once symptoms improve, steroids are tapered gradually over 4 to 6 weeks to prevent the side effect from rebounding. Tapering too quickly is a common cause of symptom recurrence, so the slow reduction matters.
For endocrine side effects that become permanent, “recovery” means adjusting to hormone replacement rather than waiting for the gland to heal. Most patients find that once the right replacement dose is established, they feel largely back to normal. The adjustment period to find the correct dose can take several weeks to a few months.
Overall, the majority of Opdivo side effects are temporary and manageable. The exceptions are primarily hormonal, and even those are treatable with replacement therapy. The key variable is which organ system is involved: skin and infusion reactions resolve fastest, gut and lung inflammation take weeks to months, and endocrine damage may be lifelong but medically manageable.